Every SEC Form 3/4/5 on record for this filer (CIK 1544328) — 17 issuers, 21 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ZFOX | ZeroFox Holdings, Inc. | 10% owner · lapsed | 2022-08-05 → 2024-05-15 | 2 | — |
| SYBX | SYNLOGIC, INC. | 10% owner · lapsed | 2017-08-30 → 2023-10-06 | 3 | — |
| OYST | Oyster Point Pharma, Inc. | 10% owner · lapsed | 2019-10-30 → 2023-01-04 | 3 | — |
| IMRA | IMARA Inc. | 10% owner · lapsed | 2020-03-11 → 2022-04-07 | 11 | −$201,723 |
| CSPR | Casper Sleep Inc. | 10% owner · lapsed | 2020-02-06 → 2022-01-26 | 3 | — |
| MRSN | Mersana Therapeutics, Inc. | 10% owner · lapsed | 2017-06-27 → 2020-09-16 | 6 | — |
| SURF | Surface Oncology, Inc. | 10% owner · lapsed | 2018-04-18 → 2020-05-22 | 3 | $2M |
| CSBR | CHAMPIONS ONCOLOGY, INC. | 10% owner · lapsed | 2020-03-10 → 2020-03-10 | 1 | — |
| GRTX | Galera Therapeutics, Inc. | 10% owner · lapsed | 2019-11-06 → 2019-11-12 | 2 | — |
| ADAP | Adaptimmune Therapeutics PLC | 10% owner · lapsed | 2016-01-04 → 2018-09-10 | 5 | — |
| MULE | MULESOFT, INC | 10% owner · lapsed | 2017-03-16 → 2018-05-09 | 3 | — |
| TCON | Tracon Pharmaceuticals, Inc. | 10% owner · lapsed | 2016-11-29 → 2018-03-27 | 2 | — |
| APPN | APPIAN CORP | 10% owner · lapsed | 2017-05-24 → 2018-02-15 | 5 | −$55M |
| SBBP | Strongbridge Biopharma plc | 10% owner · lapsed | 2018-01-09 → 2018-01-09 | 1 | — |
| ILIU | INTERLEUKIN GENETICS INC | 10% owner · lapsed | 2016-08-02 → 2016-08-02 | 1 | $2M |
| CERC | Cerecor Inc. | 10% owner · lapsed | 2015-10-14 → 2015-10-20 | 2 | — |
| MIRN | Mirna Therapeutics, Inc. | 10% owner · lapsed | 2015-09-30 → 2015-10-06 | 2 | $6M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| IMRA | 2022-01-25 | Sell | 102,952 | $1.47 | $151,339 | 3,305,601 |
| IMRA | 2022-01-24 | Sell | 19,984 | $1.55 | $30,975 | 3,408,553 |
| IMRA | 2022-01-21 | Sell | 11,622 | $1.67 | $19,409 | 3,428,537 |
| SURF | 2018-04-23 | Buy | 133,333 | $15.00 | $2M | 3,312,877 |
4 of 17 issuers are covered and open a security page; the rest are on file here only.
